Beijing Aosaikang Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001X92
CNY
17.03
-0.27 (-1.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
490.73
500.46
386.31
455.96
468.37
442.18
321.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
490.73
500.46
386.31
455.96
468.37
442.18
321.12
Raw Material Cost
102.89
96.36
86.90
89.78
95.28
90.30
79.36
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.32
0.32
1.31
0.00
1.09
0.53
1.26
Selling and Distribution Expenses
274.85
309.53
282.74
282.68
294.24
276.99
220.03
Other Expenses
2.84
5.60
0.73
3.85
5.48
5.85
5.24
Total Expenditure (Excl Depreciation)
406.43
462.16
378.22
410.94
445.42
426.27
353.09
Operating Profit (PBDIT) excl Other Income
84.3
38.3
8.100000000000001
45
23
15.9
-32
Other Income
11.59
9.71
19.85
0.21
18.40
10.73
38.57
Operating Profit (PBDIT)
127.30
80.75
48.01
69.04
64.00
50.41
25.93
Interest
0.32
0.32
1.31
0.00
1.09
0.53
1.26
Exceptional Items
3.38
4.42
2.59
5.07
2.55
2.52
9.10
Gross Profit (PBDT)
387.85
404.10
299.41
366.18
373.10
351.88
241.76
Depreciation
32.35
32.35
23.11
23.11
22.98
22.98
21.10
Profit Before Tax
98.01
52.50
26.18
50.99
42.48
29.43
12.66
Tax
2.32
0.75
8.00
8.02
4.60
2.37
1.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.26
54.73
33.28
51.42
44.05
31.54
36.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.26
54.73
33.28
51.42
44.05
31.54
36.13
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.87
-3.70
-14.49
-6.29
-5.94
-5.11
-23.64
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
96.39
51.03
18.79
45.14
38.11
26.43
12.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,138.60
3,145.02
3,062.65
2,987.64
2,936.42
2,911.06
2,899.99
Earnings per share (EPS)
0.11
0.06
0.04
0.06
0.05
0.03
0.04
Diluted Earnings per share
0.11
0.06
0.04
0.06
0.05
0.03
0.04
Operating Profit Margin (Excl OI)
16.99%
7.73%
1.31%
10.03%
4.83%
3.78%
-10.51%
Gross Profit Margin
26.56%
16.95%
12.76%
16.25%
13.98%
11.85%
10.51%
PAT Margin
21.45%
10.94%
8.61%
11.28%
9.4%
7.13%
11.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -1.96% vs 29.56% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 89.02% vs 171.28% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 62.96% vs 151.77% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -76.92% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Beijing Aosaikang Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
490.73
0
490.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
490.73
0
490.73
Raw Material Cost
102.89
0
102.89
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.32
0
0.32
Selling and Distribution Expenses
274.85
0
274.85
Other Expenses
2.84
0.00
2.84
Total Expenditure (Excl Depreciation)
406.43
0
406.43
Operating Profit (PBDIT) excl Other Income
84.31
0.00
84.31
Other Income
11.59
0
11.59
Operating Profit (PBDIT)
127.30
0
127.30
Interest
0.32
0
0.32
Exceptional Items
3.38
0
3.38
Gross Profit (PBDT)
387.85
0
387.85
Depreciation
32.35
0
32.35
Profit Before Tax
98.01
0
98.01
Tax
2.32
0
2.32
Provisions and contingencies
0
0
0.00
Profit After Tax
105.26
0
105.26
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
105.26
0
105.26
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.87
0
-8.87
Other related items
0.00
0.00
0.00
Consolidated Net Profit
96.39
0
96.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,138.60
0
3,138.60
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
16.99%
0%
0.00
16.99%
Gross Profit Margin
26.56%
0%
0.00
26.56%
PAT Margin
21.45%
0%
0.00
21.45%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 49.07 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -1.96% vs 29.56% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4.76% vs 27.28% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.64 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 89.02% vs 171.28% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 153.02% vs 136.11% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.57 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 62.96% vs 151.77% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 153.73% vs 148.72% in Jun 2024

Quarterly - Interest
Interest 0.03 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -76.92% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -72.73% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.99%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024